Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1960 1
1963 1
1964 1
1965 2
1966 1
1969 1
1970 2
1971 1
1972 3
1974 2
1975 6
1976 7
1977 6
1978 1
1979 4
1980 5
1981 3
1982 3
1983 5
1984 1
1985 2
1986 5
1987 2
1988 2
1989 4
1990 1
1991 3
1992 1
1993 3
1994 1
1995 1
1996 3
1997 3
1998 3
1999 2
2000 2
2001 4
2002 3
2003 3
2004 4
2005 5
2006 5
2007 7
2008 4
2009 3
2010 3
2011 3
2012 2
2013 4
2014 5
2015 8
2016 6
2017 4
2018 3
2019 12
2020 7
2021 14
2022 11
2023 8
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

208 results

Results by year

Filters applied: . Clear all
Page 1
Therapy Failure and Resistance Mechanism in Eyelid and Ocular Surface Tumors.
Ju X, Gaca P, Fan W, Rokohl AC, Guo Y, Wawer Matos PA, Emmert S, Kakkassery V, Heindl LM. Ju X, et al. Neurosignals. 2022 Aug 25;30(S1):21-38. doi: 10.33594/000000560. Neurosignals. 2022. PMID: 36005157 Free article. Review.
Malignant tumors of the eyelids and ocular surface are common ocular malignancies. At present, surgical treatment is mostly the first choice for these types of tumors. However, postoperative tumor recurrence and metastasis are still regarded as
Malignant tumors of the eyelids and ocular surface are common ocular malignancies. At present, surgical treatment is mo
Clinicopathological features of patients with wide local excision of eyelid malignant neoplasms: a more than five years retrospective study from China.
Han Y, Kong M, Luo Y, Sun B, Wang Z, Zhang H. Han Y, et al. BMC Ophthalmol. 2022 Nov 15;22(1):436. doi: 10.1186/s12886-022-02645-y. BMC Ophthalmol. 2022. PMID: 36376823 Free PMC article.
BACKGROUND: To investigate the correlation between the clinical and pathological characteristics and outcomes in patients with eyelid malignant tumors underwent wide local excision. METHODS: This retrospective study included 141 cases of eyelid mali
BACKGROUND: To investigate the correlation between the clinical and pathological characteristics and outcomes in patients with eyelid
Prognostic factors for local recurrence, metastasis and survival for sebaceous carcinoma of the eyelid: observations in 100 patients.
Sa HS, Rubin ML, Xu S, Ning J, Tetzlaff M, Sagiv O, Kandl TJ, Esmaeli B. Sa HS, et al. Br J Ophthalmol. 2019 Jul;103(7):980-984. doi: 10.1136/bjophthalmol-2018-312635. Epub 2018 Aug 21. Br J Ophthalmol. 2019. PMID: 30131380
BACKGROUND/AIMS: To validate the predictive value of the American Joint Committee on Cancer (AJCC) 8th-edition classification for local recurrence, metastasis and survival in patients with eyelid sebaceous carcinoma. ...CONCLUSIONS: T and N categories per AJC …
BACKGROUND/AIMS: To validate the predictive value of the American Joint Committee on Cancer (AJCC) 8th-edition classification for local
Modified argon laser therapy for benign tumor of the eyelid.
Han J, Lee SH, Choi CY, Khoramnia R, Kim J, Shin HJ. Han J, et al. BMC Ophthalmol. 2022 Sep 24;22(1):383. doi: 10.1186/s12886-022-02601-w. BMC Ophthalmol. 2022. PMID: 36153503 Free PMC article.
METHODS: Nineteen benign tumors of the eyelid were included in this study. After staining the surface of the tumor with a violet marker, low-energy argon laser photoablation was performed. ...CONCLUSIONS: Our modified method of argon laser therapy utilizes the stain …
METHODS: Nineteen benign tumors of the eyelid were included in this study. After staining the surface of the tumor with a viol …
Eccrine Ductal Carcinoma of the Eyelid.
Casale JJ, Uddin SB, Proia AD. Casale JJ, et al. Ophthalmic Plast Reconstr Surg. 2023 Nov-Dec 01;39(6):e199-e202. doi: 10.1097/IOP.0000000000002465. Epub 2023 Jul 21. Ophthalmic Plast Reconstr Surg. 2023. PMID: 37486338
The authors present the third example of an eccrine ductal carcinoma of the eyelid. A woman in her early 70s presented with a lesion of the central right lower eyelid margin in the vicinity where an actinic keratosis was diagnosed by biopsy 2.75 years previously. .. …
The authors present the third example of an eccrine ductal carcinoma of the eyelid. A woman in her early 70s presented with a lesion …
Clinical features and prognosis of sebaceous carcinoma arising in the eyelid or conjunctiva.
Goto H, Tsubota K, Nemoto R, Ueda S, Umazume K, Usui Y, Matsumura H. Goto H, et al. Jpn J Ophthalmol. 2020 Sep;64(5):549-554. doi: 10.1007/s10384-020-00756-x. Epub 2020 Jul 8. Jpn J Ophthalmol. 2020. PMID: 32642990
Local recurrence was detected in 11 cases (9%). Metastasis to the regional lymph nodes was confirmed in 10 cases (9%). Four patients (3%) died because of direct intracranial invasion of the tumor. Risk of local recurrence and metastasis was sign
Local recurrence was detected in 11 cases (9%). Metastasis to the regional lymph nodes was confirmed in 10 cases (9%). Four pa
Eyelid sebaceous carcinoma: Validation of the 8th edition of the American Joint Committee on cancer T staging system and the prognostic factors for local recurrence, nodal metastasis, and survival.
Hsia Y, Yeh CY, Wei YH, Chen LW, Liao SL. Hsia Y, et al. Eye (Lond). 2019 Jun;33(6):887-895. doi: 10.1038/s41433-019-0454-7. Epub 2019 May 31. Eye (Lond). 2019. PMID: 31147618 Free PMC article.
RESULTS: The distribution of T1:T2:T3:T4 tumours according to the 7th and 8th edition was 6:40:16:1 and 23:26:5:9, respectively. Positive surgical margin was a poor prognostic factor. Local recurrence was associated with more aggressive histopathological features an …
RESULTS: The distribution of T1:T2:T3:T4 tumours according to the 7th and 8th edition was 6:40:16:1 and 23:26:5:9, respectively. Positive su …
Long-term outcomes of margin-controlled excision for eyelid melanoma.
Bladen JC, Malhotra R, Litwin A. Bladen JC, et al. Eye (Lond). 2023 Apr;37(5):1009-1013. doi: 10.1038/s41433-023-02428-9. Epub 2023 Feb 24. Eye (Lond). 2023. PMID: 36828958 Free PMC article.
Further excisions were performed in nine (41%); two went on to recur. Local recurrence was 36%; six invasive (27%) at a mean of 24 months (range 1.5-5 years) and two for MIS at a mean of 15 months (range 1-1.5 years). ...More studies are needed to determine the best …
Further excisions were performed in nine (41%); two went on to recur. Local recurrence was 36%; six invasive (27%) at a mean o …
Treatment of Metastatic Eyelid Carcinoma.
Bonavolontà P, Dell'Aversana Orabona G, Abbate V, Iaconetta G, Bonavolontà G, Califano L. Bonavolontà P, et al. J Craniofac Surg. 2017 Nov;28(8):e722-e725. doi: 10.1097/SCS.0000000000003847. J Craniofac Surg. 2017. PMID: 28885435
The clinical records of 10 patients with malignant eyelid carcinoma and regional nodal metastasis treated between September 2011 and March 2015 have been analyzed. ...The follow-up time ranged from 9 to 36 months (median 19.3 months). CONCLUSIONS: Patients affected …
The clinical records of 10 patients with malignant eyelid carcinoma and regional nodal metastasis treated between September 20 …
Reconstruction of Medial Canthal Ligament With Autogenous Fascia Lata Graft.
Wang Y, Yuan Y, Pang L. Wang Y, et al. J Craniofac Surg. 2023 Sep 1;34(6):e604-e607. doi: 10.1097/SCS.0000000000009537. Epub 2023 Jul 10. J Craniofac Surg. 2023. PMID: 37427931 Free PMC article.
BACKGROUND: An eyelid malignant tumor invading the medial canthus is a serious eyelid disease that requires extensive resection and complex destruction. ...The mean follow-up time was 13.63.51 months (range, 8-24 mo). There was no tumor recur
BACKGROUND: An eyelid malignant tumor invading the medial canthus is a serious eyelid disease that requires exte …
208 results